UP tops India’s medicine trade; chemists must ensure drug safety: CM

Gorakhpur:  Chief minister Yogi Adityanath on Sunday urged the pharmaceutical sector to act responsibly against counterfeit medicines, calling them a serious threat to public health. Addressing the annual program of the Chemists and Druggists Federation, he said, “Uttar Pradesh is the country’s largest consumer market for medicines, with over 1.10 lakh registered medical shops and nearly five lakh people engaged in this trade. The responsibility is immense.”

He stressed, “Maintaining public trust is the biggest capital in the pharmaceutical business. Spurious drugs are a direct threat to public health. Society must remain alert, and chemists must ensure these practices are completely eliminated.”

He also urged a crackdown on illegal narcotics sales, citing recent government actions in Agra and other districts. Highlighting the crackdown on illegal narcotics, he added, “Traders who expose illegal activities will have full government support and protection.”

On transforming UP into a pharmaceutical hub, he said, “This will create new opportunities, ensure better and safer healthcare, boost exports, and generate large-scale employment.” A large pharma park is under development in Lalitpur, and former drug controller general Dr GN Singh has been appointed as the state’s pharma advisor.

On GST reforms, CM Yogi noted that the September 3 GST Council meeting reduced tax rates on medicines and made life-saving insurance policies almost GST-free, benefiting both consumers and traders.

The event was attended by minister of state for food safety Dayashankar Mishra Dayalu, Gorakhpur MP Ravi Kishan Shukla, mayor Dr Manglesh Srivastava, MLC and BJP state vice president Dr Dharmendra Singh, and representatives from state medicine associations.

Related Posts

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Lundbeck, a biopharmaceutical company focusing exclusively on brain health, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to asedebart (Lu AG13909), Lundbeck’s novel…

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India, a leader in advanced diagnostic imaging and healthcare technology, has installed and commissioned the Fujifilm Echelon Smart MRI at Jansons Health in Erode. The installation expands access to…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

US FDA grants orphan drug designation for Lundbeck’s investigational anti-ACTH monoclonal antibody asedebart to treat endogenous Cushing’s syndrome

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Fujifilm India installs Echelon Smart MRI at Jansons Health in Erode

Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

Rajasthan to prepare ‘Narcotics Control Vision 2026-29’ to curb drug abuse and trafficking

Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

Bracco Imaging expands BubbleGen cell selection with CD3+ T Cell Isolation Kit

5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

5 medicine samples found substandard in Bhiwadi warehouse raid; probe launched

AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure

AiMeD welcomes govt’s offer supporting development of advanced testing infrastructure